Stay updated with breaking news from Myovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enzalutamide alone and with leuprolide led to greater rates of undetectable PSA levels vs leuprolide alone in castration-sensitive prostate cancer.
This newsletter reports on U.S. legal matters relevant to Japanese companies. This edition covers U.S. court cases and cross-border transactions from the winter of 2023-24. Among other things...
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The
Olaparib plus abiraterone acetate delayed disease progression and improved outcomes in patients with BRCA-, ATM- and CDK12-mutated mCRPC.
Women's health and FemTech companies have seen recent fundraising gains, political attention, and success stories. If these trends hold, 2024 may be their standout year.